Stifel on Inari Medical Inc. (NARI): 'Quick Thoughts on the Deal and PEN Implications'
Tweet Send to a Friend
Stifel analyst Matthew Blackman reiterated a Hold rating and $50.00 price target on Inari Medical Inc. (NASDAQ: NARI)The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
